Demant
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 c
Tags Tree
Selected: 0
No matching results found.
- Provide a detailed account of your organization's significant operational and capital expenditures necessary for the execution of your climate change mitigation transition plan, as outlined in Disclosure Requirement E1-1. This should include an explanation and quantification of investments and funding, referencing the key performance indicators of taxonomy-aligned capital expenditures, and, where applicable, the capital expenditure plans disclosed in accordance with Commission Delegated Regulation (EU) 2021/2178.
-
Question Id: E1-1_04
The financial resources required for the implementation of the decarbonisation levers and their relation to the financial statements are yet to be determined, as this depends on further defining the decarbonisation levers and their mitigation actions.
Report Date: 4Q2024Relevance: 30%
- What is the percentage of contractual instruments utilized for the sale and purchase of unbundled energy attribute claims in relation to Scope 2 GHG emissions? Provide details on the share and types of these contractual instruments, considering both location-based and market-based methods for calculating Scope 2 GHG emissions, as outlined in Disclosure Requirement E1-9.
-
Question Id: E1-6_22
35% of the Group’s electricity consumption is now covered by renewable sources, mainly from electricity vendors (directly sourced) and Energy Attribute Certificates.
Report Date: 4Q2024Relevance: 60%